Skip to main content
. 2015 Aug;185(8):2259–2268. doi: 10.1016/j.ajpath.2015.04.015

Table 1.

Number of Rats Intracranially Infected with Different Activated Taenia solium Oncosphere Doses Using Extraparenchymal (Type 1) and Intraparenchymal (Type 2) Routes

No. of oncospheres Extraparenchymal route
Intraparenchymal route
P
No. (%) of rats with cysts/without cyst No. (%) of ELISA-positive rats No. (%) of WB-positive rats No. (%) of rats with cysts/without cyst No. (%) of ELISA-positive rats No. (%) of WB-positive rats
0 0/6 (0) 0 0 0/6 (0) 0 0
30 3/3 (50) 1 (33) 1 (33) 6/0 (100) 5 (83) 3 (50) 0.05
60 3/3 (50) 1 (33) 3 (100) 5/1 (83) 5 (100) 3 (60) 0.23
90 4/2 (67) 3 (75)§ 3 (50) 1/5 (16.7) 1 (100) 1 (100) 0.07
180 4/2 (67) 2 (50) 1 (25) 5/1 (83) 2 (40) 3 (60) 0.52
360 3/3 (50) 3 (100) 2 (67) 5/1 (83) 3 (60) 4 (80) 0.23
720 5/1 (83) 5 (100) 4 (80) 5/1 (83) 4 (80) 4 (80) 1.0
Total 22/14 (61) 15/22 (68) 14/22 (63) 27/9 (75) 20/27 (74) 18/27 (66.7) 0.21

ELISA, enzyme-linked immunosorbent assay; WB, Western blot.

Type 1 inoculation at 2-mm depth.

Type 2 inoculation at 4-mm depth.

P value of the two-sample test of proportions of rats that develop cysticerci in the brain between intraparenchymal and extraparenchymal route of infection.

§

One rat was ELISA positive and WB negative.

One rat was WB positive and ELISA negative.